Life Time shares are down 15% since reporting Q3 results, but a push into GLP-1s could bring investor confidence back.
Hims' new platform will roll out just in time for New Year’s resolutions, but will lean on generic medications instead of highly popular GLP-1s.
Noom co-founder Saeju Jeong will continue as the wellness company's executive chairman of the board after serving as CEO for 16 years.
Jenny Craig, the famed weight loss and nutrition company, filed for Chapter 7 bankruptcy in May after four decades in business.
Novo Nordisk has filed lawsuits against wellness clinics and spas for selling non-FDA-approved versions of its weight-loss drugs.
While body positivity was popular in recent years, the pendulum seems to have swung the other way with the rise of weight-loss medications.
According to Barclays, the weight-loss drug industry could even climb as high as $200 billion within the next decade.
Sign Up to Our Newsletter
